Novartis inks global licensing & research collaboration pact with Regenerex ... pharmabiz.com The hematopoietic stem cell-based FCRx platform has been investigated in kidney transplantation to induce stable immunological tolerance, resulting in graft survival without the need for lifelong immunosuppression. This collaboration reaffirms the ... |
